UNCOVERseq enables sensitive and controlled gene editing off-target nomination across CRISPR-Cas modalities and systems — UCSF

CRISPR gene editing promises new therapies but raises concerns about unintended changes. Here, authors present UNCOVERseq, an in-cell method that sensitively detects rare off-target edits, benchmarks performance across editors, and improves risk assessment in therapeutic cells.